Moleculin Biotech Inc Working Capital to Net Assets Ratio
Moleculin Biotech Inc working capital to net assets ratio. Moleculin Biotech Inc (MBRX) has a Working Capital to Net Assets ratio of 18.9% as of December 2025. Working capital of $2.83 Million (current assets of $9.69 Million minus current liabilities of $6.85 Million) is measured against net assets of $15.01 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Moleculin Biotech Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Moleculin Biotech Inc (2015–2025)
Working capital to net assets ratio of Moleculin Biotech Inc from 2015 to 2025. This chart shows how Moleculin Biotech Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 18.9%, reflecting working capital of $2.83 Million against net assets of $15.01 Million USD. See defensive interval ratio of Moleculin Biotech Inc to measure how many days the company can operate on defensive assets alone.
Moleculin Biotech Inc Working Capital to Net Assets Ratio by Year (2015–2025)
Moleculin Biotech Inc working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Moleculin Biotech Inc from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MBRX total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 18.9% | $2.83 Million | $15.01 Million | $9.69 Million | $6.85 Million | ▲ +21.6 pp |
| 2024 | -2.8% | $-165.00K | $5.98 Million | $5.19 Million | $5.36 Million | ▼ -77.4 pp |
| 2023 | 74.6% | $19.46 Million | $26.07 Million | $26.27 Million | $6.82 Million | ▼ -3.5 pp |
| 2022 | 78.1% | $40.78 Million | $52.19 Million | $45.60 Million | $4.82 Million | ▼ -9.1 pp |
| 2021 | 87.2% | $68.88 Million | $78.99 Million | $72.50 Million | $3.62 Million | ▲ +7.4 pp |
| 2020 | 79.8% | $14.28 Million | $17.89 Million | $17.20 Million | $2.92 Million | ▲ +16.1 pp |
| 2019 | 63.7% | $9.91 Million | $15.57 Million | $13.48 Million | $3.57 Million | ▲ +35.0 pp |
| 2018 | 28.7% | $4.10 Million | $14.27 Million | $7.97 Million | $3.88 Million | ▼ -6.9 pp |
| 2017 | 35.6% | $6.09 Million | $17.12 Million | $8.30 Million | $2.21 Million | ▲ +9.6 pp |
| 2016 | 25.9% | $3.88 Million | $14.96 Million | $5.22 Million | $1.35 Million | ▼ -74.1 pp |
| 2015 | 100.0% | $-744.70K | $-744.70K | $28.09K | $772.79K | — |